Jason Pitofsky - 07 Aug 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
VP Controller
Signature
/s/**Jason Pitofsky
Issuer symbol
REGN
Transactions as of
07 Aug 2024
Net transactions value
-$339,702
Form type
4
Filing time
07 Aug 2024, 16:40:11 UTC
Previous filing
08 Feb 2024
Next filing
10 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $181,388 +487 +12% $372.46 4,691 07 Aug 2024 Direct
transaction REGN Common Stock Sale $521,090 -487 -10% $1070.00 4,204 07 Aug 2024 Direct
holding REGN Common Stock 10 07 Aug 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -487 -100% $0.000000* 0 07 Aug 2024 Common Stock 487 $372.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.